Skip Navigation
Skip to contents

Ann Dermatol.  2010 Feb;22(1):48-50. 10.5021/ad.2010.22.1.48.

A Case of p-ANCA-Positive Propylthiouracil-Induced Pyoderma Gangrenosum

Affiliations
  • 1Department of Dermatology, Maryknoll Medical Center, Busan, Korea. drj715@naver.com
  • 2Department of Dermatology, College of Medicine, Inje University, Busan, Korea.

Abstract

Propylthiouracil is a common medication used in patients with hyperthyroidism; it can cause perinuclear antineutrophil cytoplasmic antibodies (p-ANCA) in some patients with Graves' disease. This antibody has been associated with various forms of vasculitis and neutrophilic dermatosis. Herein, we report a patient who presented with cutaneous manifestations of pyoderma gangrenosum with simultaneous development of p-ANCAs during PTU therapy for Graves' disease.

Keyword

p-ANCA; Propylthiouracil; Pyoderma gangrenosum

MeSH Terms

Antibodies, Antineutrophil Cytoplasmic
Graves Disease
Humans
Neutrophils
Propylthiouracil
Pyoderma
Pyoderma Gangrenosum
Skin Diseases
Vasculitis
Antibodies, Antineutrophil Cytoplasmic
Propylthiouracil
Full Text Links
  • AD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2026 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr